DS-8201a in HER2-positive Gastric Cancer That Cannot Be Surgically Removed or Has Spread (DESTINY-Gastric02)
Conditions
- Adenocarcinoma Gastric Stage IV With Metastases
- Adenocarcinoma - GEJ
Interventions
- DRUG: Trastuzumab deruxtecan
Sponsor
Daiichi Sankyo
Collaborators